Literature DB >> 25856633

Role of TGF-β Signaling in Remodeling of Noncoronary Artery Aneurysms in Kawasaki Disease.

Aaron M Lee1, Chisato Shimizu1, Toshiaki Oharaseki2, Kei Takahashi2, Lori B Daniels3, Andrew Kahn3, Robert Adamson4, Walter Dembitsky4, John B Gordon5, Jane C Burns1.   

Abstract

Coronary artery aneurysms (CAA) remain an important complication of Kawasaki disease (KD), the most common form of pediatric acquired heart disease in developed countries. Potentially life-threatening CAA develop in 25% of untreated children and 5% of children treated with high-dose intravenous immunoglobulin during the acute phase of the self-limited vasculitis. Noncoronary artery aneurysms (NCAA) in extraparenchymal, muscular arteries occur in a minority of patients with KD who also have CAA, yet little is understood about their formation and remodeling. We postulated that activation of the transforming growth factor-β (TGF-β) pathway in KD may influence formation and remodeling of aneurysms in iliac, femoral, and axillary arteries, the most common sites for NCAA. We studied a resected axillary artery from one adult and endarterectomy tissue from the femoral artery from a second adult, both with a history of CAA and NCAA following KD in infancy. Histology of the axillary artery aneurysm revealed destruction of the internal elastic lamina and recanalization of organized thrombus, while the endarterectomy specimen showed dense calcification and luminal myofibroblastic proliferation. Immunohistochemistry for molecules in the TGF-β signaling pathway revealed increased expression of TGF-β2, TGF-β receptor 2, and phosphorylated SMAD3. These findings suggest ongoing tissue remodeling of the aneurysms decades after the acute injury and demonstrate the importance of the TGF-β signaling pathway in this process.

Entities:  

Keywords:  Kawasaki disease; aneurysms; axillary artery; endarterectomy; femoral artery; iliac artery

Mesh:

Substances:

Year:  2015        PMID: 25856633     DOI: 10.2350/14-12-1588-OA.1

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  7 in total

1.  Urotensin 2 in Kawasaki disease pathogenesis.

Authors:  Cassidy Y Huang; Jane C Burns; Chisato Shimizu
Journal:  Pediatr Res       Date:  2017-08-16       Impact factor: 3.756

Review 2.  Review: Found in Translation: International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease.

Authors:  Jane C Burns; Isabelle Koné-Paut; Taco Kuijpers; Chisato Shimizu; Adriana Tremoulet; Moshe Arditi
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

Review 3.  Management of sequelae of Kawasaki disease in adults.

Authors:  John B Gordon; Jane C Burns
Journal:  Glob Cardiol Sci Pract       Date:  2017-10-31

4.  CHDGKB: a knowledgebase for systematic understanding of genetic variations associated with non-syndromic congenital heart disease.

Authors:  Lan Yang; Yang Yang; Xingyun Liu; Yongquan Chen; Yalan Chen; Yuxin Lin; Yan Sun; Bairong Shen
Journal:  Database (Oxford)       Date:  2020-01-01       Impact factor: 3.451

5.  Kawasaki Disease-like Vasculitis Facilitates Atherosclerosis, and Statin Shows a Significant Antiatherosclerosis and Anti-Inflammatory Effect in a Kawasaki Disease Model Mouse.

Authors:  Yusuke Motoji; Ryuji Fukazawa; Ryosuke Matsui; Noriko Nagi-Miura; Yasuo Miyagi; Yasuhiko Itoh; Yosuke Ishii
Journal:  Biomedicines       Date:  2022-07-26

6.  Genome-wide DNA methylome alterations in acute coronary syndrome.

Authors:  Dandan Li; Jing Yan; Yunlong Yuan; Cheng Wang; Jia Wu; Qingwen Chen; Jiaxi Song; Junjun Wang
Journal:  Int J Mol Med       Date:  2017-10-27       Impact factor: 4.101

7.  Interleukin 10 and Transforming Growth Factor Beta Polymorphisms as Risk Factors for Kawasaki Disease: A Case-Control Study and Meta-Analysis.

Authors:  Farzaneh Rahmani; Vahid Ziaee; Raheleh Assari; Maryam Sadr; Arezou Rezaei; Zeinab Sadr; Seyed Reza Raeeskarami; Mohammad Hassan Moradinejad; Yahya Aghighi; Nima Rezaei
Journal:  Avicenna J Med Biotechnol       Date:  2019 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.